Rhabdomyolysis in Severe Covid19: A Mini Review Study

(2022) Rhabdomyolysis in Severe Covid19: A Mini Review Study. Journal of Medicinal and Chemical Sciences. pp. 82-88. ISSN 26514702 (ISSN)

Full text not available from this repository.

Abstract

Introduction: Rhabdomyolysis can be a symptom of COVID-19, with very few cases described so far. AKI and renal failure following rhabdomyolysis are a potentially dangerous complication. Diagnosis of rhabdomyolysis in COVID-19 is difficult due to overlap. Materials and Method: The present study was a PICO review that examined rhabdomyolysis in COVID-19. The documents browsed by Google Scholar, Sid and Mag Iran databases were analyzed using the keywords rhabdomyolysis, creatine kinase, COVID-19, acute renal failure. Results: Rhabdomyolysis following COVID-19 and SARS-CoV-2 reports of viral contamination of striated muscle may result in muscle destruction. Rhabdomyolysis in COVID-19 is a late complication. Evaluation of CK and myoglobin levels is important for the diagnosis of rhabdomyolysis in COVID19 patients. The mechanism of rhabdomyolysis in COVID-19 is unknown and various mechanisms are used. Conclusion: Rhabdomyolysis may cause acute kidney damage (AKI). Prompt diagnosis is a prerequisite for successful treatment and prevention of complications. © 2022 by SPC (Sami Publishing Company).

Item Type: Article
Keywords: Acute renal failure COVID-19 Creatine Kinase Rhabdomyolysis
Page Range: pp. 82-88
Journal or Publication Title: Journal of Medicinal and Chemical Sciences
Journal Index: Scopus
Volume: 5
Number: 1
Identification Number: https://doi.org/10.26655/JMCHEMSCI.2022.1.10
ISSN: 26514702 (ISSN)
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/17018

Actions (login required)

View Item View Item